Trials / Completed
CompletedNCT02271607
The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients
A Pilot Study About The Effects of Indirect-Moxibustion on Bladder- Functional Improvement and Symptoms Management in Patients With Overactive Bladder: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Korean Medicine Hospital of Pusan National University · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This pragmatic randomized controlled study aimed to evaluate the effectiveness and safety of moxibustion therapy on overactive bladder (OAB) patients.
Detailed description
Patients who diagnosed as overactive bladder aged 20 to 75 years old will be divided into two groups, one is moxibustion-therapy and the other is waiting-list group. Patients who belong to moxibustion therapy group will be treated moxibustion for 12 times by a Korean Medicine doctor. Patients who belong to waiting-list group will be prohibited to get any treatment including moxibustion for relieve the symptoms of overactive bladder, and the same moxibustion therapy with moxbiustion-therapy group will be conducted after 4 weeks. Overactive bladder symptom score (OABSS), overactive bladder-validated 8-question (OAB-V8) will be measured to evaluate the effectiveness. The number of side effect will be measured to evaluate the safety. The skin temperature of CV4, SP6 and LR3, and the tympanic temperature will be measured to study treatment mechanism.
Conditions
- Overactive Bladder
- Hyperthermia
- Urinary Frequency or Urgency Adverse Event
- Lower Urinary Tract Symptoms
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | moxibustion | The treatment schedule is three times per week for four weeks. Indirect moxa pillars and indirect-container moxibustion will be used. |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-10-22
- Last updated
- 2016-03-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02271607. Inclusion in this directory is not an endorsement.